Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

SELL
$7.57 - $12.5 $280,090 - $462,500
-37,000 Reduced 74.0%
13,000 $99,000
Q2 2022

Jul 18, 2022

BUY
$5.04 - $9.48 $252,000 - $474,000
50,000 New
50,000 $382,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $392M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Connective Portfolio Management, LLC Portfolio

Follow Connective Portfolio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Portfolio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Portfolio Management, LLC with notifications on news.